Nephro-Urology Monthly

Published by: Kowsar

Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients

Amitis Ramezani 1 , Mohammad Reza Aghasadeghi 2 , Farrokhlagha Ahmadi 3 , Effat Razeghi 3 , Ali Eslamifar 1 , Mohammad Banifazl 4 , Masoomeh Sofian 5 , Golnaz Bahramali 2 , Soheila Hekmat 2 and Arezoo Aghakhani 1 , *
Authors Information
1 Department of Clinical Research, Pasteur Institute of Iran, Tehran, IR Iran
2 Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, IR Iran
3 Nephrology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
4 Iranian Society for Support Patients With Infectious Diseases, Tehran, IR Iran
5 TPIRC (Tuberculosis and Pediatric Infectious Research Center), Arak University of Medical Sciences, Arak, IR Iran
Article information
  • Nephro-Urology Monthly: December 01, 2014, 7 (1); e22674
  • Published Online: November 30, 2014
  • Article Type: Research Article
  • Received: August 10, 2014
  • Revised: September 1, 2014
  • Accepted: September 2, 2014
  • DOI: 10.5812/numonthly.22674

To Cite: Ramezani A, Aghasadeghi M R, Ahmadi F, Razeghi E, Eslamifar A, et al. Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients, Nephro-Urol Mon. 2014 ; 7(1):e22674. doi: 10.5812/numonthly.22674.

Abstract
Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(15): 1927-38[DOI][PubMed]
  • 2. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008; 48(5): 743-6[DOI][PubMed]
  • 3. Aghakhani A, Banifazl M, Velayati AA, Eslamifar A, Ramezani A. Occult hepatitis B virus infection in hemodialysis patients: a concept for consideration. Ther Apher Dial. 2012; 16(4): 328-33[DOI][PubMed]
  • 4. Schmeltzer P, Sherman KE. Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci. 2010; 55(12): 3328-35[DOI][PubMed]
  • 5. Ozaslan M, Ozaslan E, Barsgan A, Koruk M. Mutations in the S gene region of hepatitis B virus genotype D in Turkish patients. J Genet. 2007; 86(3): 195-201[PubMed]
  • 6. Pichoud C, Seigneres B, Wang Z, Trepo C, Zoulim F. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology. 1999; 29(1): 230-7[DOI][PubMed]
  • 7. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010; 17(1): 1-15[DOI][PubMed]
  • 8. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002; 9(4): 243-57[DOI]
  • 9. Gutierrez-Garcia ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(12): 1538-42[DOI][PubMed]
  • 10. Chu CJ, Lee SD. Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander? J Gastroenterol Hepatol. 2010; 25(2): 221-3[DOI][PubMed]
  • 11. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. Journal of Hepatology. 2001; 34(3): 447-54[DOI]
  • 12. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010; 4(10): 658-61[PubMed]
  • 13. Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010; 48(1): 23-9[DOI][PubMed]
  • 14. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 15. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med. 2000; 3(4): 192-201
  • 16. Eslamifar A, Hamkar R, Ramezani A, Ahmadi F, Gachkar L, Jalilvand S, et al. Hepatitis G virus exposure in dialysis patients. Int Urol Nephrol. 2007; 39(4): 1257-63[DOI][PubMed]
  • 17. Rostami Z, Lessan Pezeshki M, Soleimani Najaf Abadi A, Einollahi B. Health related quality of life in Iranian hemodialysis patients with viral hepatitis: changing epidemiology. Hepat Mon. 2013; 13(6)[DOI][PubMed]
  • 18. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res. 2006; 123(1): 37-42[PubMed]
  • 19. Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, et al. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis. 2010; 14(4)-10[DOI][PubMed]
  • 20. Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial. 2010; 14(3): 349-53
  • 21. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34(1): 194-203[DOI][PubMed]
  • 22. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology. 2001; 34(1): 204-6[DOI][PubMed]
  • 23. Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol. 2004; 11(1): 18-25[DOI][PubMed]
  • 24. Goral V, Ozkul H, Tekes S, Sit D, Kadiroglu AK. Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J Gastroenterol. 2006; 12(21): 3420-4[PubMed]
  • 25. Oesterreicher C, Hammer J, Koch U, Pfeffel F, Sunder-Plassmann G, Petermann D, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int. 1995; 48(6): 1967-71[PubMed]
  • 26. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology. 2004; 40(5): 1072-7[DOI][PubMed]
  • 27. Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology. 2000; 32(1): 116-23[DOI][PubMed]
  • 28. Fabrizi F, Messa PG, Lunghi G, Aucella F, Bisegna S, Mangano S, et al. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther. 2005; 21(11): 1341-7[DOI][PubMed]
  • 29. Cohen GA, Goffinet JA, Donabedian RK, Conn HO. Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med. 1976; 84(3): 275-80[PubMed]
  • 30. Hung KY, Lee KC, Yen CJ, Wu KD, Tsai TJ, Chen WY. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant. 1997; 12(1): 180-3[PubMed]
  • 31. Dueymes JM, Bodenes-Dueymes M, Mahe JL, Herman B. Detection of hepatitis B viral DNA by polymerase chain reaction in dialysis patients. Kidney Int Suppl. 1993; 41-6[PubMed]
  • 32. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12(3): 378-82[DOI][PubMed]
  • 33. Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Saadat A, et al. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis. 2009; 13(6): 685-9[DOI][PubMed]
  • 34. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008; 14(9): 858-66[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments